Lyceum Pharmaceuticals
  • HOME
  • FOCUS
  • PERSPECTIVE
  • SCIENCE
  • PEOPLE
  • FOR INVESTORS

BOARD OF DIRECTORS

LARRY G. CABRAL, Ph.D.
Chief Executive Officer
Co-Founder
ROBERT L. LESSIN
Chairman of the Board
MATTHEW NUNEZ
Director

SCIENTIFIC TEAM

MICHAEL R. ROSE, Ph.D
Chief Scientist 
Co-Founder
JAMES N. KEZOS, MS (Ph.D 2017)
Physiologist
MARK A. PHILLIPS, MS
Genomicist
THOMAS T. BARTER, MS
Statistician

Kenneth R. Arnold
Research Associate 

PARTNERS

EMERALD LOGIC

Emerald Logic has created FACET, the world’s only precision analytics platform for integrated multi-omic discovery. Emerald’s bio-inspired signal processing technology is proven to solve problems impossible for other methods, by modeling the underlying biology of disease regardless of the number or complexity of available biomarkers, lab assessments, clinical history, and demographics.

BLUE PRINT BIO
Working with research partners at some of the world’s premier institutions, BluePrint Bio discovers new opportunities to bring needed treatments, diagnostics and prognostic properties to market through a proprietary, systemized process.

Site powered by Weebly. Managed by Bluehost